These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16633161)

  • 1. Comments on article by Mitte and associates: "A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder".
    Magalhães PV
    J Clin Psychopharmacol; 2006 Apr; 26(2):220-1; author reply 221. PubMed ID: 16633161
    [No Abstract]   [Full Text] [Related]  

  • 2. Placebo response in generalized anxiety: its effect on the outcome of clinical trials.
    Schweizer E; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():30-8. PubMed ID: 9363046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical alchemy for drug treatment of generalized anxiety disorder: a commentary on the meta-analysis by Baldwin et al. [BMJ 2011;342:d1199].
    Fava GA
    Psychother Psychosom; 2011; 80(5):261-3. PubMed ID: 21654185
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized anxiety disorder: between now and DSM-V.
    Allgulander C
    Psychiatr Clin North Am; 2009 Sep; 32(3):611-28. PubMed ID: 19716993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S; Loew D; Gaus W
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders.
    Bereza BG; Machado M; Einarson TR
    Ann Pharmacother; 2008 Oct; 42(10):1402-9. PubMed ID: 18728102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionable tolerability of tiagabine in generalized anxiety disorder.
    Spielmans GI
    J Clin Psychopharmacol; 2009 Jun; 29(3):314. PubMed ID: 19440099
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized anxiety disorder.
    Gale CK; Oakley-Browne M
    Am Fam Physician; 2003 Jan; 67(1):135-8. PubMed ID: 12537176
    [No Abstract]   [Full Text] [Related]  

  • 9. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders.
    Norton PJ; Price EC
    J Nerv Ment Dis; 2007 Jun; 195(6):521-31. PubMed ID: 17568301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to ensure clinical trial sensitivity in psychotropic drug development: a case study.
    Videla S; Sust M; Fresquet A; Villoria J
    Clin Ther; 2005 Feb; 27(2):252-4. PubMed ID: 15811489
    [No Abstract]   [Full Text] [Related]  

  • 11. On assessing potential efficacy for vortioxetine in generalized anxiety disorder.
    Baldwin DS; Nutt DJ
    Eur Neuropsychopharmacol; 2012 Dec; 22(12):841-3. PubMed ID: 22906521
    [No Abstract]   [Full Text] [Related]  

  • 12. [A guide to critical reading of clinical articles].
    Eliasson M
    Lakartidningen; 2000 Jun; 97(26-27):3178-9. PubMed ID: 10925577
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of benzodiazepines: do they work or not?
    Lader M
    Expert Rev Neurother; 2008 Aug; 8(8):1189-91. PubMed ID: 18671662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder.
    Mitte K; Noack P; Steil R; Hautzinger M
    J Clin Psychopharmacol; 2005 Apr; 25(2):141-50. PubMed ID: 15738745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence.
    Mula M; Pini S; Cassano GB
    J Clin Psychopharmacol; 2007 Jun; 27(3):263-72. PubMed ID: 17502773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot investigation of clinical effects of PM-33, a new anti-anxiety agent.
    Abuzzahab FS; Kulkarni AS
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1181-6. PubMed ID: 4154180
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled comparison of chlorazepate with oxazepam in neurotic anxiety.
    Boucek J; Vinar O; Novák A
    Act Nerv Super (Praha); 1974 Aug; 16(3):239-40. PubMed ID: 4153915
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome of anxiety disorders: a review of double-blind studies.
    Thuile J; Even C; Rouillon F
    Curr Opin Psychiatry; 2009 Jan; 22(1):84-9. PubMed ID: 19122539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin for generalised anxiety disorder.
    Drug Ther Bull; 2010 Feb; 48(2):19-22. PubMed ID: 20147432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.